Prognostic value of the microRNA-29 family in patients with primary osteosarcomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of the microRNA-29 family in patients with primary osteosarcomas
Authors
Keywords
Osteosarcoma, MicroRNA-29 family, Clinicopathological characteristics, Overall survival, Disease-free survival
Journal
MEDICAL ONCOLOGY
Volume 31, Issue 8, Pages -
Publisher
Springer Nature
Online
2014-07-12
DOI
10.1007/s12032-014-0037-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of microRNA-206 in Osteosarcoma Pathogenesis and Progression
- (2013) Yun-Ping Bao et al. Asian Pacific Journal of Cancer Prevention
- Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer
- (2013) Jianan Gong et al. CARCINOGENESIS
- The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
- (2013) J-N Gong et al. CELL DEATH AND DIFFERENTIATION
- The role of miRNA-29 family in cancer
- (2013) Yang Wang et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- The inhibitory role of Mir-29 in growth of breast cancer cells
- (2013) Zhenglong Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma
- (2013) Yisila Mu et al. MEDICAL ONCOLOGY
- Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma
- (2013) Jie Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma
- (2013) Zhigang Wang et al. PEDIATRIC BLOOD & CANCER
- Genetic and molecular characterization of the human Osteosarcoma 3AB-OS cancer stem cell line: A possible model for studying osteosarcoma origin and stemness
- (2012) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
- (2012) Heidi M. Namløs et al. PLoS One
- microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
- (2010) J.-J. Zhao et al. BLOOD
- The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
- (2010) M Eyholzer et al. BRITISH JOURNAL OF CANCER
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- (2010) Evan M. Kroh et al. METHODS
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
- (2009) Christoph A Gebeshuber et al. EMBO REPORTS
- Revisiting the principles of microRNA target recognition and mode of action
- (2009) Peter Brodersen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Osteosarcoma: The Same Old Drugs or More?
- (2008) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
- (2008) R. Garzon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now